Is Topiramate Effective for Migraine Prevention in Patients Less Than 18 Years of Age? A Meta-Analysis of Randomized Controlled Trials

Kai Le,Dafan Yu,Jiamin Wang,Abdoulaye Idriss Ali,Yijing Guo
DOI: https://doi.org/10.1186/s10194-017-0776-4
2017-01-01
Abstract:Mainly based on evidence of success in adults, various medications are commonly used to prevent pediatric migraines. Topiramate has been approved for migraine prevention in children as young as 12 years of age. In this meta-analysis, we aimed to assess the currently published data pertaining to the efficacy of topiramate for migraine prevention in patients less than 18 years of age.
What problem does this paper attempt to address?